Royalty Pharma PLC

RPRXNASDAQ · US

Holders

REDUCEDT+7
Urist Marshall
Royalty Pharma PLC · NASDAQ
−4,126 sh · $235.6K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+30
Bassler Bonnie L
Royalty Pharma PLC · NASDAQ
+642 sh · $37.5K
Filed 30 Sept 2026SEC Form 4view source
REDUCEDT+30
Urist Marshall
Royalty Pharma PLC · NASDAQ
−4,126 sh · $238.8K
Filed 30 Sept 2026SEC Form 4view source
REDUCEDT+30
Hite Christopher
Royalty Pharma PLC · NASDAQ
−3,927 sh · $231.4K
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Hite Christopher
Royalty Pharma PLC · NASDAQ
−96,073 sh · $5.6M
Filed 24 Sept 2026SEC Form 4view source
REDUCEDStale
Hite Christopher
Royalty Pharma PLC · NASDAQ
−16,800 sh
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Hite Christopher
Royalty Pharma PLC · NASDAQ
−100,000 sh · $6.0M
Filed 19 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Renaissance Technologies
Royalty Pharma PLC · NASDAQ
1,935,800 sh · $108.5M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Two Sigma Investments
Royalty Pharma PLC · NASDAQ
2,920,163 sh · $163.7M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Royalty Pharma PLC · NASDAQ
2,251,525 sh · $108.0M
Filed 31 Mar 2026SEC 13Fview source